As of Jan 17, 2025, Johnson & Johnson Intrinsic Value is $195.3. This suggests it may be undervalued by 32.8% compared to its current price of around $147.0.
As of Jan 17, 2025, Johnson & Johnson's Discounted Cash Flow (DCF) valuation estimates its share price at $229.2. This suggests it may be overvalued by 55.9% to its current price of around $147.0, using a discount rate of 7.2% and terminal growth rate of 3.0%.
Johnson & Johnson is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $195.3, compared to a market price of around $147.0. This suggests a potential undervaluation of 32.8%.